FDA Backtracks Over GLP-1s’ Effects on Pancreas
The U.S. Food and Drug Administration reports that its review of various animal and human studies does not show a
Read More
Byetta
Weekly Type 2 Drug to Be Delivered Via Needle Patch
A recent agreement between Zosano Pharma, Inc. and Novo Nordisk could lead to the introduction of a once-weekly drug for
Read More
First-World Type 2 Drug Market to Reach $47 Billion by 2022
A Massachusetts-based research firm concludes that the first-world market for type 2 drugs and treatments will increase from $27 billion
Read More
Byetta for Type 1s? It Could Be Possible
Many people with type 2 diabetes are familiar with Byetta, a drug that helps raise their insulin levels. But a
Read More
My Life as a Guinea Pig
Life With Type 2 Blog
Read More
Type 2: Oramed Sends Oral Insulin Test Request to FDA
Israel-based Oramed announced that it has sent an application to the Food and Drug Administration for permission to enter Phase
Read More
Lilly Says Its New Injectible Outperforms Three Popular Diabetes Drugs
Good news for Eli Lilly & Co., as well as for type 2s who appreciate the addition of new drugs
Read More
Am I Doing the Right Thing?
Readers occasionally ask us for advice about drugs they are taking. When they do, we refer their questions to a
Read More
An Update on Bydureon
Give us feedback about your experience with it
Read More
FDA Gives Long-Awaited Nod to Amylin’s Bydureon
After several years of delays and setbacks, Amylin Pharmaceuticals has received FDA approval to begin US marketing of BydureonTM. The
Read More